Selected research
Market Outlook & Growth Opportunities
Global Ultrasound AI Platform Market Outlook and Growth Opportunities 2026
Market perspective
The global Ultrasound AI Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Ultrasound AI Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Ultrasound AI Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Ultrasound AI Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Ultrasound AI Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Ultrasound AI Platform market include BrightHeart (Private, Paris, France), Diagnoly (Private, Lyon, France), Sonio (Public, Paris, France), Ultrasound AI (Private, Greenwood Village, USA), SmartAlpha (Private, Cankaya, Turkey), Caption Health (Public, Brisbane, USA), Philips (Public, Amsterdam, Netherlands), RayShape (Private, Shenzhen, China) and Intelligent Ultrasound (Public, London, UK), among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Ultrasound AI Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Ultrasound AI Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Ultrasound AI Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Ultrasound AI Platform market.
Ultrasound AI Platform Segment by Company
BrightHeart (Private, Paris, France)
Diagnoly (Private, Lyon, France)
Sonio (Public, Paris, France)
Ultrasound AI (Private, Greenwood Village, USA)
SmartAlpha (Private, Cankaya, Turkey)
Caption Health (Public, Brisbane, USA)
Philips (Public, Amsterdam, Netherlands)
RayShape (Private, Shenzhen, China)
Intelligent Ultrasound (Public, London, UK)
Butterfly Network (Public, Burlington, USA)
UltraSight (Private, Cambridge, USA)
Origin Medical (Private, Austin, USA)
Mindray (Public, Shenzhen, China)
GE HealthCare (Public, Chicago, USA)
ThinkSono (Private, London, UK)
DESKi (Private, Bordeaux, France)
Deepecho (Private, Rabat, Morocco)
BabyFlix (Private, San Diego, USA)
BioticsAI (Private, Oakland, USA)
Exo Imaging (Private, Redwood City, USA)
Us2.ai (Private, Singapore, Singapore)
RIVANNA (Private, Charlottesville, USA)
Ultrasound AI Platform Segment by Type
Cloud-Based
On-Premise
Hybrid Cloud Architecture
Ultrasound AI Platform Segment by Application
Hospital
Clinic
Others
Ultrasound AI Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Ultrasound AI Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Ultrasound AI Platform key companies, revenue, market share, and recent developments.
3. To split the Ultrasound AI Platform breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Ultrasound AI Platform market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Ultrasound AI Platform significant trends, drivers, influence factors in global and regions.
6. To analyze Ultrasound AI Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ultrasound AI Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ultrasound AI Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ultrasound AI Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ultrasound AI Platform industry.
Chapter 3: Detailed analysis of Ultrasound AI Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Ultrasound AI Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Ultrasound AI Platform in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-Based
- On-Premise
- Hybrid Cloud Architecture
Applications
- Hospital
- Clinic
- Others
Companies covered
- BrightHeart (Private, Paris, France)
- Diagnoly (Private, Lyon, France)
- Sonio (Public, Paris, France)
- Ultrasound AI (Private, Greenwood Village, USA)
- SmartAlpha (Private, Cankaya, Turkey)
- Caption Health (Public, Brisbane, USA)
- Philips (Public, Amsterdam, Netherlands)
- RayShape (Private, Shenzhen, China)
- Intelligent Ultrasound (Public, London, UK)
- Butterfly Network (Public, Burlington, USA)
- UltraSight (Private, Cambridge, USA)
- Origin Medical (Private, Austin, USA)
- Mindray (Public, Shenzhen, China)
- GE HealthCare (Public, Chicago, USA)
- ThinkSono (Private, London, UK)
- DESKi (Private, Bordeaux, France)
- Deepecho (Private, Rabat, Morocco)
- BabyFlix (Private, San Diego, USA)
- BioticsAI (Private, Oakland, USA)
- Exo Imaging (Private, Redwood City, USA)
- Us2.ai (Private, Singapore, Singapore)
- RIVANNA (Private, Charlottesville, USA)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Ultrasound AI Platform Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Ultrasound AI Platform Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Ultrasound AI Platform Market Dynamics
- 2.1 Ultrasound AI Platform Industry Trends
- 2.2 Ultrasound AI Platform Industry Drivers
- 2.3 Ultrasound AI Platform Industry Opportunities and Challenges
- 2.4 Ultrasound AI Platform Industry Restraints
3 Ultrasound AI Platform Market by Company
- 3.1 Global Ultrasound AI Platform Company Revenue Ranking in 2025
- 3.2 Global Ultrasound AI Platform Revenue by Company (2021-2026)
- 3.3 Global Ultrasound AI Platform Company Ranking (2024-2026)
- 3.4 Global Ultrasound AI Platform Company Manufacturing Base and Headquarters
- 3.5 Global Ultrasound AI Platform Company Product Type and Application
- 3.6 Global Ultrasound AI Platform Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Ultrasound AI Platform Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Ultrasound AI Platform Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Ultrasound AI Platform Market by Type
- 4.1 Ultrasound AI Platform Type Introduction
- 4.1.1 Cloud-Based
- 4.1.2 On-Premise
- 4.1.3 Hybrid Cloud Architecture
- 4.2 Global Ultrasound AI Platform Sales Value by Type
- 4.2.1 Global Ultrasound AI Platform Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Ultrasound AI Platform Sales Value by Type (2021-2032)
- 4.2.3 Global Ultrasound AI Platform Sales Value Share by Type (2021-2032)
5 Ultrasound AI Platform Market by Application
- 5.1 Ultrasound AI Platform Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Ultrasound AI Platform Sales Value by Application
- 5.2.1 Global Ultrasound AI Platform Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Ultrasound AI Platform Sales Value by Application (2021-2032)
- 5.2.3 Global Ultrasound AI Platform Sales Value Share by Application (2021-2032)
6 Ultrasound AI Platform Regional Value Analysis
- 6.1 Global Ultrasound AI Platform Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Ultrasound AI Platform Sales Value by Region (2021-2032)
- 6.2.1 Global Ultrasound AI Platform Sales Value by Region: 2021-2026
- 6.2.2 Global Ultrasound AI Platform Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Ultrasound AI Platform Sales Value (2021-2032)
- 6.3.2 North America Ultrasound AI Platform Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Ultrasound AI Platform Sales Value (2021-2032)
- 6.4.2 Europe Ultrasound AI Platform Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Ultrasound AI Platform Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Ultrasound AI Platform Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Ultrasound AI Platform Sales Value (2021-2032)
- 6.6.2 South America Ultrasound AI Platform Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Ultrasound AI Platform Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Ultrasound AI Platform Sales Value Share by Country, 2025 VS 2032
7 Ultrasound AI Platform Country-level Value Analysis
- 7.1 Global Ultrasound AI Platform Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Ultrasound AI Platform Sales Value by Country (2021-2032)
- 7.2.1 Global Ultrasound AI Platform Sales Value by Country (2021-2026)
- 7.2.2 Global Ultrasound AI Platform Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.7.2 France Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.14.2 China Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.17.2 India Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Ultrasound AI Platform Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Ultrasound AI Platform Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Ultrasound AI Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 BrightHeart (Private, Paris, France)
- 8.1.1 BrightHeart (Private, Paris, France) Company Information
- 8.1.2 BrightHeart (Private, Paris, France) Business Overview
- 8.1.3 BrightHeart (Private, Paris, France) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.1.4 BrightHeart (Private, Paris, France) Ultrasound AI Platform Product Portfolio
- 8.1.5 BrightHeart (Private, Paris, France) Recent Developments
- 8.2 Diagnoly (Private, Lyon, France)
- 8.2.1 Diagnoly (Private, Lyon, France) Company Information
- 8.2.2 Diagnoly (Private, Lyon, France) Business Overview
- 8.2.3 Diagnoly (Private, Lyon, France) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.2.4 Diagnoly (Private, Lyon, France) Ultrasound AI Platform Product Portfolio
- 8.2.5 Diagnoly (Private, Lyon, France) Recent Developments
- 8.3 Sonio (Public, Paris, France)
- 8.3.1 Sonio (Public, Paris, France) Company Information
- 8.3.2 Sonio (Public, Paris, France) Business Overview
- 8.3.3 Sonio (Public, Paris, France) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.3.4 Sonio (Public, Paris, France) Ultrasound AI Platform Product Portfolio
- 8.3.5 Sonio (Public, Paris, France) Recent Developments
- 8.4 Ultrasound AI (Private, Greenwood Village, USA)
- 8.4.1 Ultrasound AI (Private, Greenwood Village, USA) Company Information
- 8.4.2 Ultrasound AI (Private, Greenwood Village, USA) Business Overview
- 8.4.3 Ultrasound AI (Private, Greenwood Village, USA) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.4.4 Ultrasound AI (Private, Greenwood Village, USA) Ultrasound AI Platform Product Portfolio
- 8.4.5 Ultrasound AI (Private, Greenwood Village, USA) Recent Developments
- 8.5 SmartAlpha (Private, Cankaya, Turkey)
- 8.5.1 SmartAlpha (Private, Cankaya, Turkey) Company Information
- 8.5.2 SmartAlpha (Private, Cankaya, Turkey) Business Overview
- 8.5.3 SmartAlpha (Private, Cankaya, Turkey) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.5.4 SmartAlpha (Private, Cankaya, Turkey) Ultrasound AI Platform Product Portfolio
- 8.5.5 SmartAlpha (Private, Cankaya, Turkey) Recent Developments
- 8.6 Caption Health (Public, Brisbane, USA)
- 8.6.1 Caption Health (Public, Brisbane, USA) Company Information
- 8.6.2 Caption Health (Public, Brisbane, USA) Business Overview
- 8.6.3 Caption Health (Public, Brisbane, USA) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.6.4 Caption Health (Public, Brisbane, USA) Ultrasound AI Platform Product Portfolio
- 8.6.5 Caption Health (Public, Brisbane, USA) Recent Developments
- 8.7 Philips (Public, Amsterdam, Netherlands)
- 8.7.1 Philips (Public, Amsterdam, Netherlands) Company Information
- 8.7.2 Philips (Public, Amsterdam, Netherlands) Business Overview
- 8.7.3 Philips (Public, Amsterdam, Netherlands) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.7.4 Philips (Public, Amsterdam, Netherlands) Ultrasound AI Platform Product Portfolio
- 8.7.5 Philips (Public, Amsterdam, Netherlands) Recent Developments
- 8.8 RayShape (Private, Shenzhen, China)
- 8.8.1 RayShape (Private, Shenzhen, China) Company Information
- 8.8.2 RayShape (Private, Shenzhen, China) Business Overview
- 8.8.3 RayShape (Private, Shenzhen, China) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.8.4 RayShape (Private, Shenzhen, China) Ultrasound AI Platform Product Portfolio
- 8.8.5 RayShape (Private, Shenzhen, China) Recent Developments
- 8.9 Intelligent Ultrasound (Public, London, UK)
- 8.9.1 Intelligent Ultrasound (Public, London, UK) Company Information
- 8.9.2 Intelligent Ultrasound (Public, London, UK) Business Overview
- 8.9.3 Intelligent Ultrasound (Public, London, UK) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.9.4 Intelligent Ultrasound (Public, London, UK) Ultrasound AI Platform Product Portfolio
- 8.9.5 Intelligent Ultrasound (Public, London, UK) Recent Developments
- 8.10 Butterfly Network (Public, Burlington, USA)
- 8.10.1 Butterfly Network (Public, Burlington, USA) Company Information
- 8.10.2 Butterfly Network (Public, Burlington, USA) Business Overview
- 8.10.3 Butterfly Network (Public, Burlington, USA) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.10.4 Butterfly Network (Public, Burlington, USA) Ultrasound AI Platform Product Portfolio
- 8.10.5 Butterfly Network (Public, Burlington, USA) Recent Developments
- 8.11 UltraSight (Private, Cambridge, USA)
- 8.11.1 UltraSight (Private, Cambridge, USA) Company Information
- 8.11.2 UltraSight (Private, Cambridge, USA) Business Overview
- 8.11.3 UltraSight (Private, Cambridge, USA) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.11.4 UltraSight (Private, Cambridge, USA) Ultrasound AI Platform Product Portfolio
- 8.11.5 UltraSight (Private, Cambridge, USA) Recent Developments
- 8.12 Origin Medical (Private, Austin, USA)
- 8.12.1 Origin Medical (Private, Austin, USA) Company Information
- 8.12.2 Origin Medical (Private, Austin, USA) Business Overview
- 8.12.3 Origin Medical (Private, Austin, USA) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.12.4 Origin Medical (Private, Austin, USA) Ultrasound AI Platform Product Portfolio
- 8.12.5 Origin Medical (Private, Austin, USA) Recent Developments
- 8.13 Mindray (Public, Shenzhen, China)
- 8.13.1 Mindray (Public, Shenzhen, China) Company Information
- 8.13.2 Mindray (Public, Shenzhen, China) Business Overview
- 8.13.3 Mindray (Public, Shenzhen, China) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.13.4 Mindray (Public, Shenzhen, China) Ultrasound AI Platform Product Portfolio
- 8.13.5 Mindray (Public, Shenzhen, China) Recent Developments
- 8.14 GE HealthCare (Public, Chicago, USA)
- 8.14.1 GE HealthCare (Public, Chicago, USA) Company Information
- 8.14.2 GE HealthCare (Public, Chicago, USA) Business Overview
- 8.14.3 GE HealthCare (Public, Chicago, USA) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.14.4 GE HealthCare (Public, Chicago, USA) Ultrasound AI Platform Product Portfolio
- 8.14.5 GE HealthCare (Public, Chicago, USA) Recent Developments
- 8.15 ThinkSono (Private, London, UK)
- 8.15.1 ThinkSono (Private, London, UK) Company Information
- 8.15.2 ThinkSono (Private, London, UK) Business Overview
- 8.15.3 ThinkSono (Private, London, UK) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.15.4 ThinkSono (Private, London, UK) Ultrasound AI Platform Product Portfolio
- 8.15.5 ThinkSono (Private, London, UK) Recent Developments
- 8.16 DESKi (Private, Bordeaux, France)
- 8.16.1 DESKi (Private, Bordeaux, France) Company Information
- 8.16.2 DESKi (Private, Bordeaux, France) Business Overview
- 8.16.3 DESKi (Private, Bordeaux, France) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.16.4 DESKi (Private, Bordeaux, France) Ultrasound AI Platform Product Portfolio
- 8.16.5 DESKi (Private, Bordeaux, France) Recent Developments
- 8.17 Deepecho (Private, Rabat, Morocco)
- 8.17.1 Deepecho (Private, Rabat, Morocco) Company Information
- 8.17.2 Deepecho (Private, Rabat, Morocco) Business Overview
- 8.17.3 Deepecho (Private, Rabat, Morocco) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.17.4 Deepecho (Private, Rabat, Morocco) Ultrasound AI Platform Product Portfolio
- 8.17.5 Deepecho (Private, Rabat, Morocco) Recent Developments
- 8.18 BabyFlix (Private, San Diego, USA)
- 8.18.1 BabyFlix (Private, San Diego, USA) Company Information
- 8.18.2 BabyFlix (Private, San Diego, USA) Business Overview
- 8.18.3 BabyFlix (Private, San Diego, USA) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.18.4 BabyFlix (Private, San Diego, USA) Ultrasound AI Platform Product Portfolio
- 8.18.5 BabyFlix (Private, San Diego, USA) Recent Developments
- 8.19 BioticsAI (Private, Oakland, USA)
- 8.19.1 BioticsAI (Private, Oakland, USA) Company Information
- 8.19.2 BioticsAI (Private, Oakland, USA) Business Overview
- 8.19.3 BioticsAI (Private, Oakland, USA) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.19.4 BioticsAI (Private, Oakland, USA) Ultrasound AI Platform Product Portfolio
- 8.19.5 BioticsAI (Private, Oakland, USA) Recent Developments
- 8.20 Exo Imaging (Private, Redwood City, USA)
- 8.20.1 Exo Imaging (Private, Redwood City, USA) Company Information
- 8.20.2 Exo Imaging (Private, Redwood City, USA) Business Overview
- 8.20.3 Exo Imaging (Private, Redwood City, USA) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.20.4 Exo Imaging (Private, Redwood City, USA) Ultrasound AI Platform Product Portfolio
- 8.20.5 Exo Imaging (Private, Redwood City, USA) Recent Developments
- 8.21 Us2.ai (Private, Singapore, Singapore)
- 8.21.1 Us2.ai (Private, Singapore, Singapore) Company Information
- 8.21.2 Us2.ai (Private, Singapore, Singapore) Business Overview
- 8.21.3 Us2.ai (Private, Singapore, Singapore) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.21.4 Us2.ai (Private, Singapore, Singapore) Ultrasound AI Platform Product Portfolio
- 8.21.5 Us2.ai (Private, Singapore, Singapore) Recent Developments
- 8.22 RIVANNA (Private, Charlottesville, USA)
- 8.22.1 RIVANNA (Private, Charlottesville, USA) Company Information
- 8.22.2 RIVANNA (Private, Charlottesville, USA) Business Overview
- 8.22.3 RIVANNA (Private, Charlottesville, USA) Ultrasound AI Platform Revenue and Gross Margin (2021-2026)
- 8.22.4 RIVANNA (Private, Charlottesville, USA) Ultrasound AI Platform Product Portfolio
- 8.22.5 RIVANNA (Private, Charlottesville, USA) Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst